Fasting-dietary therapy and intermittent fasting as a unifi ed treatment and preventive strategy for age-associated human diseases

Changing dietary patterns plays a leading role, especially as a means against obesity and related metabolic diseases. Over the past decades, intermittent fasting regimens have gained popularity as an alternative to traditional weight loss strategies such as fasting-diet therapy and hypocaloric diets. Available literature suggests that intermittent fasting, taking into account the specifi c characteristics and needs of a person, can be recommended both as part of an individual program for weight loss and treatment of metabolic diseases, and after long cycles of fasting-dietary therapy in order to maintain positive treatment results in the long term. This review shows that the methods of complete fasting, low-calorie nutrition and intermittent fasting are eff ective non-pharmacological interventions for the correction of cardiometabolic disorders that contribute to an increase in life expectancy and suppression of oncogenesis and it is advisable to consider them within the framework of a unifi ed treatment and preventive strategy for age-associated human pathology

1. Ohsumi Y. Historical landmarks of autophagy research. Cell. Res. 2014;24(1):9–23. DOI: 10.1038/cr.2013.169

2. Klionsky D.J., Petroni G., Amaravadi R.K., Baehrecke E.H., Ballabio A., Boya P. et al. Autophagy in major human diseases. EMBO J. 2021;40(19):e108863. DOI: 10.15252/embj.2021108863

3. Silveira Rossi J.L., Barbalho S.M., Reverete de Araujo R., Bechara M.D., Sloan K.P., Sloan L.A. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes Metab. Res. Rev. 2022;38:e3502. DOI: 10.1002/dmrr.3502

4. Maksimov V.A. Fasting-dietary therapy for diseases of the digestive system. In: Non-drug methods for treating diseases of the digestive system. M. Adamant. 2018:289–339. (In Russian).

5. Berkovskaya M.A., Gurova O.Y., Khaykina I.A., Fadeev V.V. Time-restricted eating as a novel strategy for treatment of obesity and it’s comorbid conditions. Problems of Endocrinology. 2022;68(4):78–91. (In Russian) DOI http://dx.doi.org/10.14341/probl13078

6. Sharma S.K., Mudgal S.K., Kalra S., Gaur R., Thakur K., Agarwal R. Eff ect of intermittent fasting on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. touchREV Endocrinol. 2023;19(1):25– 32. DOI: 10.17925/EE.2023.19.1.25

7. Shazman S. Understanding type 2 diabetes mellitus risk parameters through intermittent fasting: a machine learning approach. Nutrients. 2023;15(18):3926. DOI: 10.3390/nu15183926

8. Naous E., Achkar A., Mitri J. Intermittent fasting and its eff ects on weight, glycemia, lipids, and blood pressure: a narrative review. Nutrients. 2023;15(16):3661. DOI: 10.3390/nu15163661

9. Aragon A.A., Schoenfeld B.J. Does timing matter? A narrative review of intermittent fasting variants and their eff ects on bodyweight and body Composition. Nutrients. 2022;14(23):5022. DOI: 10.3390/nu14235022

10. Elortegui Pascual P., Rolands M.R., Eldridge A.L., Kassis A., Mainardi F., Lê K.A., Karagounis L.G., Gut P., Varady K.A. A meta-analysis comparing the eff ectiveness of alternate day fasting, the 5:2 diet, and time-restricted eating for weight loss. Obesity. 2023;31(1):9–21. DOI: 10.1002/oby.23568

11. Recommendations for the management of patients with metabolic syndrome: clinical guidelines. M. 2013:43. (In Russian). [Electronic resource]. URL: https://mzdrav.rk.gov.ru/file/mzdrav_18042014_Klinicheskie_ rekomendacii_Metabolicheskij_sindrom.pdf

12. Jiang Y., Yang X., Dong C., Lu Y., Yin H., Xiao B. et al. Five-day water-only fasting decreased metabolic-syndrome risk factors and increased anti-aging biomarkers without toxicity in a clinical trial of normal-weight individuals. Clin. Transl. Med. 2021;11(8):e502. DOI: 10.1002/ctm2.502

13. Ogłodek E., Pilis W. Is water-only fasting safe? Glob. Adv. Health Med. 2021;10:21649561211031178. DOI: 10.1177/21649561211031178

14. Scharf E., Zeiler E., Ncube M., Kolbe P., Hwang S.Y., Goldhamer A., Myers T.R. The eff ects of prolonged water-only fasting and refeeding on markers of cardiometabolic risk. Nutrients. 2022;14(6):1183. DOI: 10.3390/nu14061183

15. Gabriel S., Ncube M., Zeiler E., Thompson N., Karlsen M.C., Goldman D.M. et al. A six-week follow-up study on the sustained eff ects of prolonged water-only fasting and refeeding on markers of cardiometabolic Risk. Nutrients. 2022;14(20):4313. DOI: 10.3390/nu14204313

16. de Toledo F.W., Grundler F., Bergouignan A., Drinda S., Michalsen A. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One. 2019;14:e0209353. DOI: 10.1371/journal.pone.0209353

17. Schroor M.M., Joris P.J., Plat J., Mensink R.P. Eff ects of intermittent energy restriction compared with those of continuous energy restriction on body composition and cardiometabolic risk markers — a systematic review and meta-analysis of randomized controlled trials in adults. Adv. Nutr. 2024;15(1):100130. DOI: 10.1016/j.advnut.2023.10.003

18. Carter S., Clifton P.M., Keogh J.B. Eff ect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes: a randomized noninferiority trial. JAMA Netw. Open. 2018;1(3):e180756. DOI: 10.1001/jamanetworkopen.2018.0756

19. Kunduraci Y.E., Ozbek H. Does the energy restriction intermittent fasting diet alleviate metabolic syndrome biomarkers? a randomized controlled trial. Nutrients. 2020;12(10):3213. DOI: 10.3390/nu12103213

20. Petko A.P., Khudziev B.G., Mikhailov N.E., Evdokimov A.S., Isaeva O.L. The role of fasting and dietary therapy in the complex non-drug treatment of hypertension. Voyenno-meditsinskiy zhurnal. 2015;336(2):55–57. (In Russian). [Electronic resource]. URL: https://journals.eco-vector.com/0026-9050/issue/view/3968

21. Kodela P., Okeke M., Guntuku S., Lingamsetty S.S.P., Slonovschi E. Management of hypertension with non-pharmacological interventions: a narrative review. Cureus. 2023;15(8):e43022. DOI: 10.7759/cureus.43022

22. Ghadieh A.S., Saab B. Evidence for exercise training in the management of hypertension in adults. Can. Fam. Physician. 2015; 61(3): 233–239. [Electronic resource]. URL: https://www.cfp.ca/content/cfp/61/3/233.full.pdf

23. Longo V.D., Mattson M.P. Fasting: molecular mechanisms and clinical applications. Cell Metab. 2014;19(2):181–192. DOI: 10.1016/j.cmet.2013.12.008

24. Redman L.M., Smith S.R., Burton J.H., Martin C.K., Il’yasova D., Ravussin E. Metabolic slowing and reduced oxidative damage with sustained caloric restriction support the rate of living and oxidative damage theories of aging. Cell Metab. 2018;27(4):805–815. DOI: 10.1016/j.cmet.2018.02.019

25. Rozing M.P., Westendorp R.G., de Craen A.J., Frölich M., Heijmans B.T., Beekman M. et al. Low serum free triiodothyronine levels mark familial longevity: the Leiden Longevity Study. J. Gerontol. A Biol. Sci. Med. Sci. 2010;65(4):365–368. DOI: 10.1093/gerona/glp200

26. Ravussin E., Redman L.M., Rochon J., Das S.K., Fontana L., Kraus W.E. et al. A 2-year randomized controlled trial of human caloric restriction: feasibility and eff ects on predictors of health span and longevity. J. Gerontol. A Biol. Sci. Med. Sci. 2015;70(9):1097– 1104. DOI: 10.1093/gerona/glv057

27. Stekovic S., Hofer S.J., Tripolt N., Aon M.A., Royer P., Pein L. et al. Alternate day fasting improves physiological and molecular markers of aging in healthy, non-obese humans. Cell Metab. 2019;30(3):462– 476. DOI: 10.1016/j.cmet.2019.07.016

28. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Infl amm-aging. An evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 2000;908:244–254. DOI: 10.1111/j.1749-6632.2000.tb06651.x

29. Wei M., Brandhorst S., Shelehchi M., Mirzaei H., Cheng C.W., Budniak J.et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci. Transl. Med. 2017;9(377):eaai8700. DOI: 10.1126/scitranslmed.aai8700

30. Jiang Y., Tang Z., Zhu X., Xiao B., Tian H., Lei X. et al. Non-invasive

31. omics analysis delineates molecular changes in water-only fasting and its sex-discriminating features in metabolic syndrome patients. Med. Comm. (2020). 2023;4(6):e393. DOI: 10.1002/mco2.393

32. Vitale G., Brugts M.P., Ogliari G., Castaldi D., Fatti L.M., Varewijck A.J. et al. Low circulating IGF-I bioactivity is associated with human longevity: fi ndings in centenarians’ off spring. Aging (Albany NY). 2012;4(9):580–589. DOI: 10.18632/aging.100484

33. Thissen J.P., Ketelslegers J.M., Underwood L.E. Nutritional regulation of the insulin-like growth factors. Endocr. Rev.1994;15(1):80–101. DOI: 10.1210/edrv-15-1-80

34. Fontana L., Partridge L., Longo V.D. Dietary restriction, growth factors and aging: from yeast to humans. Science. 2010;328(5976):321–326. DOI: 10.1126/science.1172539

35. Fontana L., Weiss E.P., Villareal D.T., Klein S., Holloszy J.O. Longterm eff ects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell. 2008;7(5):681–687. DOI: 10.1111/j.1474-9726.2008.00417.x

36. Jamshed H., Beyl R.A., Della Manna D.L., Yang E.S., Ravussin E., Peterson C.M. Early time-restricted feeding improves 24-hour glucose levels and aff ects markers of the circadian clock, aging, and autophagy in humans. Nutrients. 2019;11(6):1234. DOI: 10.3390/nu11061234

37. Nencioni A., Caff a I., Cortellino S., Longo V.D. Fasting and cancer: molecular mechanisms and clinical application. Nat. Rev. Cancer. 2018;18(11):707–719. DOI: 10.1038/s41568-018-0061-0

38. Salvioli S., Capri M., Bucci L., Lanni C., Racchi M., Uberti D., Memo M., Mari D., Govoni S., Franceschi C. Why do centenarians escape or postpone cancer? The role of IGF-1, infl ammation and p53. Cancer Immunol. Immunother. 2009;58(12):1909–17. DOI: 10.1007/s00262-008-0639-6

39. Guevara-Aguirre J., Balasubramanian P., Guevara-Aguirre M., Wei M., Madia F., Cheng C.W. et al. Growth hormone receptor defi ciency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 2011;3(70):70ra13. DOI: 10.1126/scitranslmed.3001845

40. Shevah O., Laron Z. Patients with congenital defi ciency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Horm IGF Res. 2007;17(1):54–57. DOI: 10.1016/j.ghir.2006.10.007

41. de Groot S., Lugtenberg R.T., Cohen D., Welters M.J.P., Ehsan I., Vreeswijk M.P.G. et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nat. Commun. 2020;11(1):3083– 3093. DOI: 10.1038/s41467-020-16138-3

42. Safdie F.M., Dorff T., Quinn D., Fontana L., Wei M., Lee C., Cohen P., Longo V.D. Fasting and cancer treatment in humans: A case series report. Aging (Albany NY). 2009;1(12):988–1007. DOI: 10.18632/aging.100114

43. Ferro Y., Maurotti S., Tarsitano M.G., Lodari O., Pujia R., Mazza E. et al. Therapeutic fasting in reducing chemotherapy side eff ects in cancer patients: a systematic review and meta-analysis. Nutrients. 2023;15(12):2666. DOI: 10.3390/nu15122666

44. Zhong Z., Zhang H., Nan K., Zhong J., Wu Q., Lu L. et al. Fastingmimicking diet drives antitumor immunity against colorectal cancer by reducing iga-producing cells. Cancer Res. 2023;83(21):3529– 3543. DOI: 10.1158/0008-5472.CAN-23-0323